Total Funding
56
42
Total FundingSeries A raised
Growth Score 56 in past quarter
4 pts
Heat Score 42 in past quarter
-7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
228611
Elixir Medical provides drug-device treatment solutions for the treatment of cardiovascular patients.
- Alex Nepogodiev: Executive Vice President, of Global Marketing
- Richard Castro: EVP Finance & AdministrationPast Role: Arstasis, Sr. Vice President, Finance and Operations
About the Company
Elixir Medical Corporation, a privately held company headquartered in Sunnyvale, CA, specializes in developing products that combine state-of-the-art medical devices with advanced pharmaceuticals.
The company's next-generation drug-eluting stent systems are designed to optimize localized drug delivery to provide a safe and effective treatment
for cardiovascular patients.

